Intellia Therapeutics, Inc. (NTLA) vs Precigen, Inc. (PGEN)

• Intellia Therapeutics, Inc. NTLA 11.27 ▲ +1.53%
• Precigen, Inc. PGEN 4.43 ▲ +4.98%

Intellia Therapeutics, Inc. and Precigen, Inc. are both Biotechnology companies. Intellia Therapeutics, Inc. and Precigen, Inc. are of similar size ($1.6B and $1.5B). Intellia Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Precigen, Inc. trades at 60.3×. Precigen, Inc. grew revenue faster over the last twelve months: 2,387.6% against −8.07%. Precigen, Inc. has the higher net margin (15.6% vs −805.8%) and the higher return on invested capital (15.9% vs −195.3%). Across the 18 metrics below, Precigen, Inc. leads on 12 and Intellia Therapeutics, Inc. on 6.